iifl-logo

Shilpa Medicare Ltd Historical Data

966
(4.80%)
Jun 10, 2025|01:14:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Shilpa Medicare Ltd Historical Data

10/05/2025calendar-icon
10/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-May-2025

647.7

663.3640650.759,5717,07,33,922.645,586

13-May-2025

650.8

684.4650.8669.4512,22913,16,83,709.9568,926

14-May-2025

670

707.5667.55694.915,71515,16,45,105.0586,866

15-May-2025

701.2

729.45701.2714.921,57226,78,75,497.151,23,066

16-May-2025

719.6

719.8699.1707.9518,76412,71,81,769.0577,852

19-May-2025

707.95

722702711.4511,80710,24,21,733.6562,430

20-May-2025

715

720699.95703.8518,61910,97,93,789.796,272

21-May-2025

705.9

729696.95702.4516,97419,01,36,118.31,05,156

22-May-2025

704.1

747704.1735.626,00630,49,93,486.451,67,812

23-May-2025

743

804.4723783.3534,84672,55,11,013.254,21,752

26-May-2025

800

898798.05890.251,63,0554,15,11,50,03410,24,911

27-May-2025

854

904.5847.45874.655,4321,37,89,23,829.053,78,321

28-May-2025

875

896.2869.5886.2521,83444,45,10,857.11,39,436

29-May-2025

880

900879.3892.617,76335,92,87,9051,64,427

30-May-2025

892.1

924.2889.2901.420,12352,38,98,006.62,79,097

02-Jun-2025

899.55

901.4875.5885.655,36710,52,85,785.1560,281

03-Jun-2025

885.9

890.55865874.95,8089,55,69,484.444,438

04-Jun-2025

871.7

894.75858.15883.65,70810,15,39,210.850,318

05-Jun-2025

889.6

905.45885.05898.76,69016,15,93,738.61,03,915

06-Jun-2025

914.95

924.9902914.4513,62428,32,43,613.21,55,512

09-Jun-2025

922

939910921.7520,45737,52,73,316.851,65,170

Shilpa Medicare: Related NEWS

Shilpa Medicare Receives EU GMP Approval for Bengaluru Manufacturing Unit
8 May 2025|12:30 AM

The certification came after a successful inspection by the Finnish Medicines Agency on behalf of EMA from March 10 to March 14, 2025

Read More
Shilpa Medicare Strikes Global Immuno-Oncology Deal with mAbTree
18 Mar 2025|01:22 PM

The partnership will work on a new biological entity (NBE) in the immuno-oncology field to better treat cancer.

Read More
Top Stocks for Today - 18th March 2025
18 Mar 2025|06:44 AM

Here are some of the stocks that may see significant price movement today: Aditya Birla Real Estate, Shilpa Medicare, Swiggy, etc.

Read More
Shilpa Pharma Lifesciences Clears USFDA Inspection at Raichur Unit-2
16 Mar 2025|11:29 PM

No regulatory issues were raised by the USFDA at Unit-2 during the inspection, the company said in a regulatory filing.

Read More
Shilpa Medicare Gets CDSCO Nod for NAFLD Drug
13 Feb 2025|11:09 PM

Shilpa Medicare said it has completed Phase 3 trials for SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets in 165 NAFLD patients in India.

Read More
Shilpa Medicare Secures EU GMP Certification for Hyderabad Facility
23 Dec 2024|01:30 PM

The certification followed a successful inspection by the European Medicines Agency, Austria, held from September 24 to September 26 at the Nacharam, Hyderabad facility.

Read More
Shilpa Medicare’s JV Oncosol Gets FDA Nod for IMKELDI
28 Nov 2024|12:41 AM

This FDA approval is a milestone in cancer therapy as it presents a more convenient and precise alternative to the traditional tablet forms.

Read More
Shilpa Medicare Secures Phase III Trial Nod for Recombinant Albumin
26 Nov 2024|07:49 PM

  Shilpa Medicare is the first Indian company to gain approval for Phase III trials of Recombinant Human Albumin.

Read More
Shilpa Medicare Subsidiary Bags European Certification for Nifedipine
19 Nov 2024|05:28 PM

The European Directorate for the Quality of Medicines & Healthcare (EDQM) gave Shilpa Pharma Lifesciences, the company's subsidiary, the Certificate of Suitability (CEP) for Nifedipine.

Read More
Top 10 stocks for today - 4th October, 2024
4 Oct 2024|08:46 AM

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Bank of Baroda, HDFC Bank, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.